With a decision due from the FDA early next year on its ACAM2000 smallpox vaccine, Acambis plc took an order from the feds for 10 million more doses at a price of about $30 million, and disclosed separately that $19 million is due from Novartis AG to settle the dispute over another vaccine. (BioWorld Today) Read More
